- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期行情可能回暖，可适量买进股票，作短线反弹行情。
- 中期趋势：
已发现中线卖出信号。
- 长期趋势：
已有20家主力机构披露2025-06-30报告期持股数据，持仓量总计1.66亿股，占流通A股31.60%
- 波段诊断：
-
技术面诊股
诊断结果：2.8技术面打败了1%的股票
技术面评分前10的股票
近期的平均成本为8.70元。空头行情中，并且有加速下跌的趋势。已发现中线卖出信号。
平均成本
近期的平均成本为8.70元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.70","date":1770020291,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑输行业平均水平。
[{"date":"2026.02.03","stock":"4.87","trade":null,"ind":"1.29"},{"date":"2026.02.02","stock":"0.24","trade":null,"ind":"-2.48"},{"date":"2026.01.30","stock":"-0.71","trade":null,"ind":"-0.96"},{"date":"2026.01.29","stock":"-0.70","trade":null,"ind":"0.16"},{"date":"2026.01.28","stock":"-2.52","trade":null,"ind":"0.27"},{"date":"2026.01.27","stock":"-3.74","trade":null,"ind":"0.18"},{"date":"2026.01.26","stock":"-3.92","trade":null,"ind":"-0.09"},{"date":"2026.01.23","stock":"0.75","trade":null,"ind":"0.33"},{"date":"2026.01.22","stock":"-0.11","trade":null,"ind":"0.14"},{"date":"2026.01.21","stock":"0.75","trade":null,"ind":"0.08"},{"date":"2026.01.20","stock":"-2.10","trade":null,"ind":"-0.01"},{"date":"2026.01.19","stock":"2.15","trade":null,"ind":"0.29"},{"date":"2026.01.16","stock":"-2.61","trade":null,"ind":"-0.26"},{"date":"2026.01.15","stock":"-1.95","trade":null,"ind":"-0.33"},{"date":"2026.01.14","stock":"0.31","trade":null,"ind":"-0.31"},{"date":"2026.01.13","stock":"-1.02","trade":null,"ind":"-0.64"},{"date":"2026.01.12","stock":"0.10","trade":null,"ind":"1.09"},{"date":"2026.01.09","stock":"1.55","trade":null,"ind":"0.92"},{"date":"2026.01.08","stock":"0.73","trade":null,"ind":"-0.07"},{"date":"2026.01.07","stock":"-1.64","trade":null,"ind":"0.05"},{"date":"2026.01.06","stock":"3.17","trade":null,"ind":"1.50"}]
济民健康,上证指数,医疗器械指数
压力支撑
该股压力位为8.62元，支撑位为8.32元。
[{"text":"\u538b\u529b\u4f4d","value":"8.62","date":1770048000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.32","date":1770048000,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。已发现中线卖出信号。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.4资金面打败了56%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：02月03日 16:47
| 机构今日流向(万元) | 555.77 | 机构5日流向(万元) | -6944.56 |
| 机构10日流向(万元) | -10638.75 | 机构20日流向(万元) | -19636.56 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少680.31万股，其中基金净减仓5家，主力净减仓12家，请投资者中长期谨慎为宜。
截止2025-06-30，共20家主力机构（基金16家，一般法人4家），持仓量总计16592.12万股，占流通A股31.60%
其中，基金持仓与2024-12-31相比：
增仓：4家 ，增持 4.26万股
减仓：9家 ，减持 18.40万股
新出现在主力名单中：4家 ，持有366.47万股
从主力名单中消失：16家 ，原持有1027.39万股
其中，基金持仓与2024-12-31相比：
增仓：4家 ，增持 4.26万股
减仓：9家 ，减持 18.40万股
新出现在主力名单中：4家 ，持有366.47万股
从主力名单中消失：16家 ，原持有1027.39万股
消息面诊股
诊断结果：1.6消息面打败了2%的股票
今日有利好新闻的公司
近期利空消息较多且有重大利空，消息面发出消极信号。
更多>>个股资讯
- 济民健康：公司暂无代理销售尼帕病毒相关检测试剂产品
2026-02-03 - 济民健康：公司旗下博鳌国际医院生物药物研发管线除D
2026-02-03 - 济民健康：2月2日获融资买入370.19万元
2026-02-03 - 济民健康：1月30日获融资买入379.71万元
2026-01-31 - 济民健康：1月29日获融资买入305.19万元
2026-01-30 - 济民健康：1月28日获融资买入426.32万元
2026-01-29 - 济民健康：目前公司生产经营正常，暂不存ST风险
2026-01-28 - 济民健康：DB006溶瘤腺病毒注射液尚未获得默认许
2026-01-28 - 济民健康：1月27日获融资买入628.36万元
2026-01-28 - 济民健康：1月26日获融资买入1096.94万元
2026-01-27
消息列表
| 重大利空 | 业绩预告 | 预计增亏 | 2026-01-24 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-01 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-11-14 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-26 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-21 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-29 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-29 |
| 一般消息 | 高管变动 | 涉嫌伪造公司印章罪 | 2025-03-28 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了8%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.02.03","price":"1.29","value":null},{"date":"2026.02.02","price":"-2.48","value":null},{"date":"2026.01.30","price":"-0.96","value":null},{"date":"2026.01.29","price":"0.16","value":null},{"date":"2026.01.28","price":"0.27","value":null},{"date":"2026.01.27","price":"0.18","value":null},{"date":"2026.01.26","price":"-0.09","value":null},{"date":"2026.01.23","price":"0.33","value":null},{"date":"2026.01.22","price":"0.14","value":null},{"date":"2026.01.21","price":"0.08","value":null},{"date":"2026.01.20","price":"-0.01","value":null},{"date":"2026.01.19","price":"0.29","value":null},{"date":"2026.01.16","price":"-0.26","value":null},{"date":"2026.01.15","price":"-0.33","value":null},{"date":"2026.01.14","price":"-0.31","value":null},{"date":"2026.01.13","price":"-0.64","value":null},{"date":"2026.01.12","price":"1.09","value":null},{"date":"2026.01.09","price":"0.92","value":null},{"date":"2026.01.08","price":"-0.07","value":null},{"date":"2026.01.07","price":"0.05","value":null},{"date":"2026.01.06","price":"1.50","value":"-357279036.44"}]
上证指数,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 华兰股份 | 66.63% | 2.13% | 5.9分 |
| 2 | 宝莱特 | 47.26% | -3.59% | 5.3分 |
| 3 | 天智航 | 43.67% | -0.58% | 5.6分 |
| 4 | 康众医疗 | 39.75% | -9.88% | 5.0分 |
| 5 | 凯普生物 | 29.38% | -15.98% | 5.5分 |
| 6 | 西山科技 | 19.83% | -2.04% | 5.9分 |
| 8 | 三友医疗 | 16.09% | -4.82% | 6.6分 |
| 10 | 港通医疗 | 14.18% | 3.24% | 5.4分 |
| 12 | 爱迪特 | 11.83% | -5.11% | 6.0分 |
| 14 | 爱威科技 | 10.92% | 0.61% | 6.5分 |
| 16 | 赛科希德 | 9.92% | -1.49% | 5.6分 |
| 18 | 洁特生物 | 9.16% | -0.87% | 6.0分 |
| 20 | 济高发展 | 7.35% | -5.35% | 5.2分 |
| 22 | 天益医疗 | 7.07% | -4.34% | 5.1分 |
| 24 | 黄山胶囊 | 6.87% | 1.48% | 6.4分 |
| 26 | 戴维医疗 | 6.72% | 0.35% | 6.4分 |
| 28 | ST凯利 | 6.29% | -0.98% | 5.8分 |
| 30 | 楚天科技 | 5.86% | -6.45% | 4.7分 |
| 32 | 海泰新光 | 4.61% | -2.75% | 5.8分 |
| 34 | 迈克生物 | 4.42% | -9.40% | 4.8分 |
| 36 | 乐心医疗 | 4.25% | -2.51% | 5.4分 |
| 38 | 英科医疗 | 3.97% | -7.12% | 4.8分 |
| 40 | 阳普医疗 | 3.81% | -2.39% | 6.3分 |
| 42 | 之江生物 | 3.73% | -17.71% | 4.9分 |
| 44 | 力诺药包 | 3.33% | -3.63% | 5.2分 |
| 46 | 华强科技 | 3.18% | 2.36% | 5.9分 |
| 48 | 正川股份 | 3.00% | -1.10% | 5.2分 |
| 50 | 圣湘生物 | 2.46% | -9.54% | 5.5分 |
| 52 | 万孚生物 | 2.38% | -16.46% | 4.2分 |
| 54 | 艾德生物 | 1.86% | -6.31% | 5.3分 |
| 56 | - | 1.51% | -7.54% | 分 |
| 58 | 威高骨科 | 1.15% | -3.55% | 6.0分 |
| 60 | 蓝帆医疗 | 0.69% | -2.98% | 4.7分 |
| 62 | 科华生物 | 0.65% | -13.12% | 3.9分 |
| 64 | 九安医疗 | 0.56% | -6.41% | 5.5分 |
| 66 | 海尔生物 | 0.34% | -5.58% | 5.1分 |
| 68 | 鱼跃医疗 | 0.15% | -5.60% | 5.3分 |
| 70 | - | -0.08% | -6.30% | 分 |
| 72 | 硕世生物 | -0.38% | -11.92% | 3.9分 |
| 74 | 易瑞生物 | -0.41% | -8.86% | 5.2分 |
| 76 | 开立医疗 | -0.54% | -3.00% | 5.2分 |
| 78 | 迪瑞医疗 | -0.98% | -4.94% | 4.3分 |
| 80 | 大博医疗 | -1.07% | -4.14% | 5.8分 |
| 82 | 正海生物 | -1.34% | -4.08% | 4.5分 |
| 84 | 康泰医学 | -1.58% | -5.02% | 4.8分 |
| 86 | 尚荣医疗 | -1.81% | -3.06% | 4.9分 |
| 88 | 东富龙 | -2.33% | -6.48% | 4.8分 |
| 90 | 中红医疗 | -2.75% | -5.91% | 4.6分 |
| 92 | 东方生物 | -2.81% | -10.07% | 5.0分 |
| 94 | 透景生命 | -3.71% | -9.22% | 3.8分 |
| 96 | 振德医疗 | -4.08% | -0.92% | 5.6分 |
| 98 | 澳华内镜 | -4.37% | -1.98% | 4.5分 |
| 100 | 新华医疗 | -5.01% | -6.00% | 4.8分 |
| 102 | 东方海洋 | -5.06% | -1.75% | 4.8分 |
| 104 | 微电生理 | -5.65% | -4.88% | 4.7分 |
| 106 | - | -6.44% | -5.82% | 分 |
| 108 | 福瑞医科 | -6.87% | -3.41% | 4.1分 |
| 110 | 亚辉龙 | -7.21% | -3.61% | 4.0分 |
| 112 | 美好医疗 | -7.77% | -2.23% | 5.2分 |
| 114 | 新产业 | -8.40% | -0.04% | 4.6分 |
| 116 | 奥美医疗 | -8.72% | -17.42% | 4.8分 |
| 118 | 浩欧博 | -9.19% | -2.11% | 4.6分 |
| 120 | 万泰生物 | -9.72% | -6.96% | 4.2分 |
| 122 | 康拓医疗 | -10.01% | 0.37% | 5.5分 |
| 124 | - | -11.10% | -4.35% | 分 |
| 126 | 惠泰医疗 | -13.06% | -6.43% | 4.8分 |
| 128 | 海利生物 | -18.45% | -21.84% | 4.1分 |
| 130 | 伟思医疗 | -19.47% | -2.45% | 4.7分 |
| 132 | 博拓生物 | -27.68% | -11.17% | 3.9分 |
| 134 | - | -30.56% | -4.51% | 分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 124/247 ， 96/247。
[{"date":"2025-09-30","value":"-5.36","vol":"2.98"},{"date":"2025-06-30","value":"-3.63","vol":"2.34"},{"date":"2025-03-31","value":"-0.93","vol":"1.16"},{"date":"2024-12-31","value":"-3.91","vol":"0.56"},{"date":"2024-09-30","value":"1.80","vol":"4.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-5.36 | -3.63 | -0.93 | -3.91 | 1.80 |
| 行业(%) | 2.98 | 2.34 | 1.16 | 0.56 | 4.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"36.11","vol":"51.73"},{"date":"2025-06-30","value":"36.87","vol":"52.04"},{"date":"2025-03-31","value":"37.63","vol":"51.41"},{"date":"2024-12-31","value":"37.31","vol":"52.51"},{"date":"2024-09-30","value":"43.25","vol":"53.36"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
36.11 | 36.87 | 37.63 | 37.31 | 43.25 |
| 行业(%) | 51.73 | 52.04 | 51.41 | 52.51 | 53.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 113/247 ， 127/247。
[{"date":"2025-09-30","value":"-20.21","vol":"0.24"},{"date":"2025-06-30","value":"-21.30","vol":"-1.07"},{"date":"2025-03-31","value":"-22.49","vol":"-0.10"},{"date":"2024-12-31","value":"-13.28","vol":"1.15"},{"date":"2024-09-30","value":"0.74","vol":"0.77"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-20.21 | -21.30 | -22.49 | -13.28 | 0.74 |
| 行业(%) | 0.24 | -1.07 | -0.10 | 1.15 | 0.77 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-371.51","vol":"-15.37"},{"date":"2025-06-30","value":"-307.10","vol":"-18.14"},{"date":"2025-03-31","value":"-191.72","vol":"-2.59"},{"date":"2024-12-31","value":"8.81","vol":"-23.09"},{"date":"2024-09-30","value":"-36.96","vol":"-19.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-371.51 | -307.10 | -191.72 | 8.81 | -36.96 |
| 行业(%) | -15.37 | -18.14 | -2.59 | -23.09 | -19.92 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 71/247 ， 27/247。
[{"date":"2025-09-30","value":"0.22","vol":"0.25"},{"date":"2025-06-30","value":"0.15","vol":"0.17"},{"date":"2025-03-31","value":"0.07","vol":"0.08"},{"date":"2024-12-31","value":"0.32","vol":"0.36"},{"date":"2024-09-30","value":"0.28","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.22 | 0.15 | 0.07 | 0.32 | 0.28 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.26","vol":"1.66"},{"date":"2025-06-30","value":"1.43","vol":"1.12"},{"date":"2025-03-31","value":"0.65","vol":"0.55"},{"date":"2024-12-31","value":"3.16","vol":"2.32"},{"date":"2024-09-30","value":"2.66","vol":"1.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.26 | 1.43 | 0.65 | 3.16 | 2.66 |
| 行业(次) | 1.66 | 1.12 | 0.55 | 2.32 | 1.64 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"2.16","vol":"14.75"},{"date":"2025-06-30","value":"-38.08","vol":"15.16"},{"date":"2025-03-31","value":"19.07","vol":"4.21"},{"date":"2024-12-31","value":"30.84","vol":"29.34"},{"date":"2024-09-30","value":"1.18","vol":"15.46"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 2.16 | -38.08 | 19.07 | 30.84 | 1.18 |
| 行业 | 14.75 | 15.16 | 4.21 | 29.34 | 15.46 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.47","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.01","vol":"2.17"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.47 | - | 1.01 | - |
| 行业 | 0.01 | 1.57 | 0.00 | 2.17 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 34/247 ， 12/247。
[{"date":"2025-09-30","value":"1.03","vol":"5.66"},{"date":"2025-06-30","value":"1.06","vol":"5.47"},{"date":"2025-03-31","value":"1.33","vol":"5.84"},{"date":"2024-12-31","value":"1.47","vol":"5.30"},{"date":"2024-09-30","value":"1.58","vol":"5.83"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.03 | 1.06 | 1.33 | 1.47 | 1.58 |
| 行业 | 5.66 | 5.47 | 5.84 | 5.30 | 5.83 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.81","vol":"4.51"},{"date":"2025-06-30","value":"0.82","vol":"4.35"},{"date":"2025-03-31","value":"1.06","vol":"4.73"},{"date":"2024-12-31","value":"1.08","vol":"4.27"},{"date":"2024-09-30","value":"1.11","vol":"4.70"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.81 | 0.82 | 1.06 | 1.08 | 1.11 |
| 行业 | 4.51 | 4.35 | 4.73 | 4.27 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 9/247 ， 11/247。
[{"date":"2025-09-30","value":"40.38","vol":"22.07"},{"date":"2025-06-30","value":"40.10","vol":"22.01"},{"date":"2025-03-31","value":"40.23","vol":"21.19"},{"date":"2024-12-31","value":"35.05","vol":"21.94"},{"date":"2024-09-30","value":"31.57","vol":"20.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
40.38 | 40.10 | 40.23 | 35.05 | 31.57 |
| 行业(%) | 22.07 | 22.01 | 21.19 | 21.94 | 20.60 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.72","vol":"0.71"},{"date":"2025-06-30","value":"0.71","vol":"0.58"},{"date":"2025-03-31","value":"0.71","vol":"0.56"},{"date":"2024-12-31","value":"0.57","vol":"0.55"},{"date":"2024-09-30","value":"0.49","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.72 | 0.71 | 0.71 | 0.57 | 0.49 |
| 行业(%) | 0.71 | 0.58 | 0.56 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"1.48","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.34","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-0.65","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.60","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]